Cited by 147Attention Deficit Hyperactivity DisorderBehavioral and Psychological StudiesPharmaceutical studies and practices

The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.

Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options

Open access

Hodgkins, Paul, Shaw, Monica, Coghill, David, Hechtman, Lily·2012·European Child & Adolescent Psychiatry

DOI 10.1007/s00787-012-0286-5PMC PMC3432777

Open this paper in CoChat — free account Open PDF

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders among school-aged children. It is highly symptomatic and associated with significant impairment. This review examines the role of stimulant medications in the treatment of children and adolescents with ADHD. Published clinical studies that compared methylphenidate- and amfetamine-based stimulants in children and adolescents with ADHD support the therapeutic utility of stimulant treatments, and suggest robust efficacy and acceptable safety outcomes in groups treated with either stimulant. Evidence-based guidelines agree that each patient with ADHD is unique and individual treatment strategies that incorporate both drug and non-drug treatment options should be sought. In seeking to optimize individual response and outcomes to stimulant therapy, important considerations include the selection of stimulant class, the choice of long- or short-acting stimulant formulations, addressing effectively any emergent adverse effects and strategies aimed at enhancing adherence to dosing regimen and persistence on therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00787-012-0286-5

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Fig. 1 Overlapping but distinct putative mechanisms of action of a methylphenidate (MPH) and b amfetamine (AMF) at the dopamine synapse. VMAT2 vesicular monoamine transporter 2CC BY · PubMed Central

Fig. 2 Effect sizes and confidence intervals for ADHD-RS and CGI outcomes in children. Black diamonds and horizontal black lines represent standardized mean difference effect sizes and 95 % confidence intervals, respectively. Pooled results are depicted as open diamonds with the effect size in the centre of the diamond and the 95 % confidence intervals depicted by the left and right extremities of the diamond. ADHD-RS attention-deficit/hyperactivity disorder rating scale, CGI clinical global impressions of ADHD severity, LDX lisdexamfetamine dimesylate, MAS mixed amfetamine salts, MPH methylphenidate, OROS osmotic release oral system, TS transdermal system. Figure adapted from Faraone [37], with permissionCC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
American Psychiatric Association (2000) · doi:10.1176/appi.books.9780890423349 · Cited by 11,069
A power primer.
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
(2005) · The Lancet · doi:10.1016/s0140-6736(05)66544-0 · Cited by 7,626
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346
Tamoxifen for early breast cancer: an overview of the randomised trials
Abe, O., Bartholomeus, S., & Piccart, M. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,180
Scottish Intercollegiate Guidelines Network
Twaddle, S., & Qureshi, S. (2005) · Evidence-based Healthcare and Public Health · doi:10.1016/j.ehbc.2005.09.008 · Cited by 4,080
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
Karapetis, C. S., Khambata-Ford, S., Jonker, D. J., O'Callaghan, C. J., Tu, D., Tebbutt, N. C., Simes, R. J., Chalchal, H., Shapiro, J. D., Robitaille, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804385 · Cited by 3,622
A 14-Month Randomized Clinical Trial of Treatment Strategies for Attention-Deficit/Hyperactivity Disorder
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Subcommittee on Attention-Deficit/Hyperactivity Disorder, S. C. O. Q. I. A. M. (2011) · Pediatrics · doi:10.1542/peds.2011-2654 · Cited by 2,185
Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Focan, C., Steinberg, S. M., Blichert-Toft, M., Forbes, J., Collins, R. D., Anderson, S., Margreiter, R., Harwood, C. S., Andersen, K., Beighton, G., et al. (1998) · PubMed · Cited by 2,146
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
Mechanisms of neurotransmitter release by amphetamines: A review
Sulzer, D., Sonders, M. S., Poulsen, N. W., & Galli, A. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.003 · Cited by 1,243
Subgroup analysis and other (mis)uses of baseline data in clinical trials
Assmann, S. F., Pocock, S. J., Enos, L. E., & Kasten, L. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02039-0 · Cited by 1,167
Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practiceand problems.
Pocock, S. J., Assmann, S. E., Enos, L. E., & Kasten, L. E. (2002) · Statistics in Medicine · doi:10.1002/sim.1296 · Cited by 1,077
Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Howell, A. (1998) · PubMed · Cited by 901
Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate
Volkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Hitzemann, R., & Pappas, N. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1325 · Cited by 885
Empirically supported psychosocial treatments for attention deficit hyperactivity disorder
Pelham Jr, W. E., Wheeler, T., & Chronis, A. (1998) · Journal of Clinical Child Psychology · doi:10.1207/s15374424jccp2702_6 · Cited by 755
European clinical guidelines for hyperkinetic disorder ? first upgrade
Taylor, E., D�pfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Rothenberger, A., Sonuga-Barke, E., et al. (2004) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-004-1002-x · Cited by 682
Self-citation
Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter
Jones, S. R., Gainetdinov, R. R., Wightman, R. M., & Caron, M. G. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01979.1998 · Cited by 626
Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine
Kuczenski, R., & Segal, D. S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052032.x · Cited by 623
The Challenge of Subgroup Analyses — Reporting without Distorting
Lagakos, S. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068070 · Cited by 504
Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis
Faraone, S. V., & Buitelaar, J. (2010) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0054-3 · Cited by 485
The Texas Children's Medication Algorithm Project: Revision of the Algorithm for Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder
PLISZKA, S. R., CRISMON, M. L., HUGHES, C. W., CORNERS, C. K., EMSLIE, G. J., JENSEN, P. S., McCRACKEN, J. T., SWANSON, J. M., & LOPEZ, M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000215326.51175.eb · Cited by 442
The Royal Australasian College of Physicians
Rosenheim, M. L. (1958) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1958.tb86419.x · Cited by 440
Attention-deficit disorder (attention-deficit/ hyperactivity disorder without hyperactivity): A neurobiologically and behaviorally distinct disorder from attention-deficit/hyperactivity disorder (with hyperactivity)
DIAMOND, A. (2005) · Development and Psychopathology · doi:10.1017/s0954579405050388 · Cited by 428
Molecular Genetics of Attention Deficit Hyperactivity Disorder
Faraone, S. V., & Mick, E. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.12.004 · Cited by 411 · cited 1×
“The aetiology of ADHD is complex, with multiple genetic and non-genetic factors implicated [22, 41].”
Background
Review: chemotherapy and hormonal therapy reduce recurrence and mortality at 15 years in early breast cancer Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687-717.
Smith, T. J., & Khatcheressian, J. L. (2005) · Cited by 401
A Comparison of the Efficacy of Medications for Adult Attention-Deficit/Hyperactivity Disorder Using Meta-Analysis of Effect Sizes
Faraone, S. V., & Glatt, S. J. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04902pur · Cited by 387
Fundamentals of Attention-Deficit/Hyperactivity Disorder: Circuits and Pathways
Arnsten, A. F. T. (2006) · The Primary Care Companion to The Journal of Clinical Psychiatry · Cited by 378
Long-acting medications for the hyperkinetic disorders: A systematic review and European treatment guideline
Banaschewski, T., Coghill, D., Santosh, P., Zuddas, A., Asherson, P., Buitelaar, J., Danckaerts, M., Döpfner, M., Faraone, S. V., Rothenberger, A., et al. (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-0549-0 · Cited by 375
Self-citation
European guidelines on managing adverse effects of medication for ADHD
(for the European Guidelines Group), Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Döpfner, M., Hamilton, R., Hollis, C., et al. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-010-0140-6 · Cited by 374
Self-citation
Mechanism of action of methylphenidate: Insights from PET imaging studies
Volkow, N. D., Fowler, J. S., Wang, G., Ding, Y., & Gatley, S. J. (2002) · Journal of Attention Disorders · doi:10.1177/070674370200601s05 · Cited by 353
Side Effects of Methylphenidate and Dexamphetamine in Children With Attention Deficit Hyperactivity Disorder: A Double-blind, Crossover Trial
Efron, D., Jarman, F. C., & Barker, M. J. (1997) · PEDIATRICS · doi:10.1542/peds.100.4.662 · Cited by 301
Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true nonresponders?
Elia, J., Borcherding, B. G., Rapoport, J. L., & Keysor, C. S. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90126-a · Cited by 294
Amphetamine induces dopamine efflux through a dopamine transporter channel
Kahlig, K. M., Binda, F., Khoshbouei, H., Blakely, R., McMahon, D. G., Javitch, J. A., & Galli, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407737102 · Cited by 284
Neuronal Mechanisms Underlying Attention Deficit Hyperactivity Disorder: The Influence of Arousal on Prefrontal Cortical Function
Brennan, A. R., & Arnsten, A. F. T. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1417.007 · Cited by 267
Separate and combined effects of methylphenidate and behavior modification on boys with attention deficit-hyperactivity disorder in the classroom.
Pelham, W. E., Carlson, C. L., Sams, S. E., Vallano, G., Dixon, M. J., & Hoza, B. (1993) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.61.3.506 · Cited by 266
Relative Efficacy of Long-Acting Stimulants on Children With Attention Deficit-Hyperactivity Disorder: A Comparison of Standard Methylphenidate, Sustained-Release Methylphenidate, Sustained-Release Dextroamphetamine, and Pemoline
Pelham, W. E., Greenslade, K. E., Vodde‐Hamilton, M., Murphy, D. A., Greenstein, J. J., Gnagy, E. M., Guthrie, K. J., Hoover, M. D., & Dahl, R. E. (1990) · PEDIATRICS · doi:10.1542/peds.86.2.226 · Cited by 249
Analysis of randomized comparative clinical trial data for personalized treatment selections
Cai, T., Tian, L., Wong, P. H., & Wei, L. J. (2010) · Biostatistics · doi:10.1093/biostatistics/kxq060 · Cited by 238
Behavioral versus Behavioral and Pharmacological Treatment in ADHD Children Attending a Summer Treatment Program
Pelham, W. E., Gnagy, E. M., Greiner, A. R., Hoza, B., Hinshaw, S. P., Swanson, J. M., Simpson, S., Shapiro, C. J., Bukstein, O. G., Baron-Myak, C., et al. (2000) · Research on Child and Adolescent Psychopathology · doi:10.1023/a:1005127030251 · Cited by 237
ADHD and the Prefrontal Cortex
Arnsten, A. F. T. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.01.018 · Cited by 220
A Closer Look at Amphetamine-Induced Reverse Transport and Trafficking of the Dopamine and Norepinephrine Transporters
Robertson, S. D., Matthies, H. J. G., & Galli, A. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8053-4 · Cited by 206
Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.
Arnsten, A. F. T. (2006) · PubMed · Cited by 203
A Comparison of Ritalin and Adderall: Efficacy and Time-course in Children With Attention-deficit/Hyperactivity Disorder
Pelham, W. E., Aronoff, H. R., Midlam, J. K., Shapiro, C. J., Gnagy, E. M., Chronis, A. M., Onyango, A. N., Forehand, G. L., Nguyen, A. H., & Waxmonsky, J. G. (1999) · PEDIATRICS · doi:10.1542/peds.103.4.e43 · Cited by 198
Systematic review of national and international guidelines on attention-deficit hyperactivity disorder
Seixas, M., Weiss, M., & Müller, U. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111412095 · Cited by 197
The neurobiological basis of ADHD
Curatolo, P., D'Agati, E., & Moavero, R. (2010) · Italian Journal of Pediatrics · doi:10.1186/1824-7288-36-79 · Cited by 189
Renal Function and Effectiveness of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Chronic Stable Coronary Disease in the Prevention of Events with ACE inhibition (PEACE) Trial
Solomon, S. D., Rice, M. M., Jablonski, K. A., Jose, P. O., DOMANSKI, M. J., Sabatine, M. S., Gersh, B. J., Rouleau, J. L., Pfeffer, M. A., & Braunwald, E. (2006) · Circulation · doi:10.1161/circulationaha.105.592733 · Cited by 188
Single and combined effects of methylphenidate and behavior therapy on the classroom performance of children with attention-deficit hyperactivity disorder
Carlson, C. L., Pelham, W. E., Milich, R., & Dixon, J. (1992) · Journal of Abnormal Child Psychology · doi:10.1007/bf00916549 · Cited by 188
Adverse Effects of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder: Epidemiology, Prevention and Management
Graham, J., & Coghill, D. (2008) · CNS Drugs · doi:10.2165/00023210-200822030-00003 · Cited by 185
Self-citation
Patterns of treatment effects in subsets of patients in clinical trials
Bonetti, M. (2004) · Biostatistics · doi:10.1093/biostatistics/kxh002 · Cited by 181
Remission versus response as the goal of therapy in ADHD: A new standard for the field?
Steele, M., Jensen, P. S., & Quinn, D. M. P. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.11.006 · Cited by 174
Systematic Review: Anti–Epidermal Growth Factor Receptor Treatment Effect Modification by KRAS Mutations in Advanced Colorectal Cancer
Dahabreh, I. J., Terasawa, T., Castaldi, P. J., & Trikalinos, T. A. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-1-201101040-00006 · Cited by 174
Methyiphenidate vs. amphetamine: Comparative review
Arnold, L. E. (2000) · Journal of Attention Disorders · doi:10.1177/108705470000300403 · Cited by 164
Continuity of Methylphenidate Treatment for Attention-Deficit/Hyperactivity Disorder
Marcus, S. C., Wan, G. J., Kemner, J. E., & Olfson, M. (2005) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.159.6.572 · Cited by 163
Patterns of treatment effects in subsets of patients in clinical trials
Bonetti, M. (2004) · Biostatistics · doi:10.1093/biostatistics/5.3.465 · Cited by 152
Advances in understanding and treating ADHD
Antshel, K. M., Hargrave, T. M., Simonescu, M., Kaul, P., Hendricks, K., & Faraone, S. V. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-72 · Cited by 140
A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder
Pelham, W. E., Gnagy, E. M., Chronis, A. M., Burrows-MacLean, L., Fabiano, G. A., Onyango, A. N., Meichenbaum, D. L., Williams, A., Aronoff, H. R., & Steiner, R. L. (1999) · PEDIATRICS · doi:10.1542/peds.104.6.1300 · Cited by 138
A Double-Blind, Placebo-Controlled Study of Adderall and Methylphenidate in the Treatment of Attention-Deficit/Hyperactivity Disorder
PLISZKA, S. R., BROWNE, R. G., OLVERA, R. L., & WYNNE, S. K. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200005000-00016 · Cited by 130
Cerebrospinal Fluid Homovanillic Acid Predicts Behavioral Response to Stimulants in 45 Boys with Attention Deficit/Hyperactivity Disorder
Castellanos, F. X., Elia, J., Kruesi, M. J. P., Marsh, W., Gulotta, C. S., Potter, W. Z., Ritchie, G. F., Hamburger, S. D., & Rapoport, J. L. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00077-q · Cited by 129
Evolution of the treatment of attention-deficit/hyperactivity disorder in children: A review
Findling, R. L. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.05.006 · Cited by 129
Section on Allergy and Immunology
(2011) · PEDIATRICS · doi:10.1542/peds.2011-2107b · Cited by 119
Medication Adherence in the MTA: Saliva Methylphenidate Samples Versus Parent Report and Mediating Effect of Concomitant Behavioral Treatment
Pappadopulos, E., Jensen, P. S., Chait, A. R., Arnold, L. E., Swanson, J. M., Greenhill, L. L., Hechtman, L., Chuang, S., Wells, K. C., Pelham, W., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31819c23ed · Cited by 112 · cited 3×
“Despite the carefully managed nature of the Multimodal Treatment Study of Children with ADHD (MTA), saliva assays for MPH revealed that approximately 25 % of 254 patients in the medication arms of the study were nonadherent on 50 % or more of repeated assays, and that barely half (54 %) were adherent at every assay po…”
BackgroundInfluentialSelf-citation
A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder
the 311 Study Group, Wigal, S. B., Kollins, S. H., Childress, A. C., & Squires, L. (2009) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-3-17 · Cited by 110
A Comprehensive In Vitro Screening of d-, l- , and dl-threo -Methylphenidate: An Exploratory Study
Markowitz, J. S., DeVane, C. L., Pestreich, L. K., Patrick, K. S., & Muniz, R. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.687 · Cited by 109
Using Meta-analysis to Compare the Efficacy of Medications for Attention-Deficit/Hyperactivity Disorder in Youths.
Faraone, S. V. (2009) · PubMed · Cited by 107
New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD.
Heal, D. J., Smith, S. L., Kulkarni, R. S., & Rowley, H. L. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.03.016 · Cited by 105
Methylphenidate vs Dextroamphetamine vs Caffeine in Minimal Brain Dysfunction: Controlled Comparison by Placebo Washout Design With Bayes' Analysis
Arnold, L. E. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280073008 · Cited by 104
ADHD in Girls: Clinical Comparability of a Research Sample
Sharp, W. S., WALTER, J. M., Marsh, W., Ritchie, G. F., HAMBURGER, S. D., & Castellanos, F. X. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199901000-00018 · Cited by 102
Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain
Easton, N., Steward, C., Marshall, F., Fone, K., & Marsden, C. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.07.035 · Cited by 101
Assessment of Adherence Measures with Different Stimulants Among Children and Adolescents
Sanchez, R. J., Crismon, M. L., Barner, J. C., Bettinger, T., & Wilson, J. P. (2005) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.7.909 · Cited by 101
Plasma levels of d-amphetamine in hyperactive children: Serial behavior and motor responses
Brown, G. L., Hunt, R. D., Ebert, M. H., Bunney, W. E., & Kopin, I. J. (1979) · Psychopharmacology · doi:10.1007/bf00427126 · Cited by 97
Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial
Efron, D., Jarman, F., & Barker, M. (1997) · PEDIATRICS · doi:10.1542/peds.100.6.e6 · Cited by 94
Progress and Promise of Attention-Deficit Hyperactivity Disorder Pharmacogenetics
Froehlich, T. E., McGough, J., & Stein, M. (2010) · CNS Drugs · doi:10.2165/11530290-000000000-00000 · Cited by 91
ADHD in Girls: Clinical Comparability of a Research Sample
Sharp, W. S., Walter, J. M., Marsh, W., Ritchie, G. F., Hamburger, S. D., & Castellanos, F. X. (2002) · Routledge eBooks · doi:10.4324/9780203449523-12 · Cited by 91
Pharmacokinetic Considerations in the Treatment of Attention-Deficit Hyperactivity Disorder with Methylphenidate
Wolraich, M. L., & Doffing, M. (2004) · CNS Drugs · doi:10.2165/00023210-200418040-00004 · Cited by 86
Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population
Christensen, L., Sasané, R., Hodgkins, P., Harley, C., & Tetali, S. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003673617 · Cited by 86
Self-citation
Stimulant drug treatment of hyperactivity: Biochemical correlates
Elia, J., Borcherding, B. G., Potter, W. Z., Mefford, I. N., Rapoport, J. L., & Keysor, C. S. (1990) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1990.118 · Cited by 83
Pharmacokinetics of methylphenidate in hyperkinetic children.
Hungund, B. L., Perel, J. M., Hurwic, M. J., Sverd, J., & Winsberg, B. G. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb01046.x · Cited by 77
Classroom Academic Performance: Improvement with both Methylphenidate and Dextroamphetamine in ADHD Boys
Elia, J., Welsh, P. A., Gulotta, C. S., & RAPOPORT, J. L. (1993) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1993.tb01071.x · Cited by 71
Dextroamphetamine and Methylphenidate in the Treatment of Hyperactive/Aggressive Children
Winsberg, B. G., Press, M., Bialer, I., & Kupietz, S. S. (1974) · PEDIATRICS · doi:10.1542/peds.53.2.236 · Cited by 65
Attention-Deficit Hyperactivity Disorder
MAY, D. E., & Kratochvil, C. J. (2009) · Drugs · doi:10.2165/11530540-000000000-00000 · Cited by 62
The Pharmacogenomic Era: Promise for Personalizing Attention Deficit Hyperactivity Disorder Therapy
Stein, M. A., & McGough, J. J. (2008) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2007.11.009 · Cited by 56
ADHD: Current and Future Therapeutics
Heal, D. J., Smith, S. L., & Findling, R. L. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_125 · Cited by 55
Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with Attention-Deficit/Hyperactivity Disorder
WILSON, H., Cox, D. J., Merkel, R. L., Moore, M. E., & Coghill, D. (2006) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2006.06.016 · Cited by 55
Self-citation
Effect of Switching Drug Formulations from Immediate-Release to Extended-Release OROS Methylphenidate: A Chart Review of Spanish Adults with Attention-Deficit Hyperactivity Disorder
Ramos-Quiroga, J. A., Bosch, R., Castells, X., Valero, S., Nogueira, M., Gómez, N., Yelmo, S., Ferrer, M., Martínez, Y., & Casas, M. (2008) · CNS Drugs · doi:10.2165/00023210-200822070-00005 · Cited by 54
Preferences for treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): a discrete choice experiment
Mühlbacher, A. C., Rudolph, I., Lincke, H.-J., & Nübling, M. (2009) · BMC Health Services Research · doi:10.1186/1472-6963-9-149 · Cited by 52
Differential effects of methylphenidate and dextroamphetamine on the motor activity level of hyperactive children
Borcherding, B. G. (1989) · Neuropsychopharmacology · doi:10.1016/0893-133x(89)90029-8 · Cited by 48
Spatial Attentional Bias as a Marker of Genetic Risk, Symptom Severity, and Stimulant Response in ADHD
Bellgrove, M. A., Barry, E., Johnson, K. A., Cox, M., Dáibhis, A., Daly, M., Hawi, Z., Lambert, D., Fitzgerald, M., McNicholas, F., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301637 · Cited by 48
PREDICTING STIMULANT MEDICATION RESPONSE IN ADHD: EVIDENCE FROM AN INTEGRATED PROFILE OF NEUROPSYCHOLOGICAL, PSYCHOPHYSIOLOGICAL AND CLINICAL FACTORS
Hermens, D. F., Cooper, N. J., Kohn, M. R., Clarke, S. P., Gordon, E., & Williams, L. M. (2005) · Journal of Integrative Neuroscience · doi:10.1142/s0219635205000653 · Cited by 48
Lisdexamfetamine dimesylate (vyvanse), a prodrug stimulant for attention-deficit/hyperactivity disorder.
Goodman, D. W. (2010) · PubMed Central · Cited by 36
Multimodal Treatments versus Pharmacotherapy Alone in Children with Psychiatric Disorders
Reeves, G. M., & Anthony, B. J. (2009) · Pediatric Drugs · doi:10.2165/00148581-200911030-00002 · Cited by 35
Understanding the Effect Size of Lisdexamfetamine Dimesylate for Treating ADHD in Children and Adults
Faraone, S. V. (2010) · Journal of Attention Disorders · doi:10.1177/1087054710379738 · Cited by 32
Assessment of parents’ preferences for the treatment of school-age children with ADHD: a discrete choice experiment
Fegert, J. M., Slawik, L., Wermelskirchen, D., Nübling, M., & Mühlbacher, A. C. (2011) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.11.22 · Cited by 29
Misleading subgroup analyses in GISSI
Peto, R. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91149-z · Cited by 23
The role of pharmacotherapy and managed care pharmacy interventions in the treatment of ADHD.
Dopheide, J. A. (2009) · PubMed · Cited by 21
Methylphenidate delivery mechanisms for the treatment of children with attention deficit hyperactivity disorder: Heterogeneity in parent preferences
Lloyd, A. J., Hodgkins, P., Dewilde, S., Sasané, R., Falconer, S., & Barke, E. S. (2011) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462311000249 · Cited by 19
Self-citation
Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD
Dew, R. E., & Kollins, S. H. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.531009 · Cited by 14
Attention deficit/hyperactivity disorder: pharmacotherapy.
Elia, J. (2005) · PubMed Central · Cited by 9
Identifying Subjects Who Benefit from Additional Information for Better Prediction of the Outcome Variables
Tian, L., Cai, T., & Wei, L. (2008) · Biometrics · doi:10.1111/j.1541-0420.2008.01125.x · Cited by 9
Stratifying Subjects for Treatment Selection with Censored Event Time Data from a Comparative Study
Zhao, L., Cai, T., Tian, L., Uno, H., Solomon, S. D., & Wei, L. J. (2010) · Collection of Biostatistics Research Archive · Cited by 7
Clinical Practice Guideline for Patients with Attention Deficit/Hyperactivity Disorder
Carlton, T. G., Donachie, N., Frampton, K. K., Henschen, G., Kumar, P. E., Parrot, L. A., Smith, C. A., Tamil, F. A., Valenti, A. M., & Waxenberg, F. (2014) · Cited by 2

Research works printed but not linked: 1

McDonagh M, Peterson K, Dana T, Thakurta S (2007) Drug Class Review on Pharamcologic Treatments for ADHD. http://www.ncbi.nlm.nih.gov/books/bookres.fcgi/adhd/pdfadhd.pdf . Accessed 27 September 2011. Oregon Health and Science University, Portland, Oregon

Sorted by citations

A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD)
Luo, Y., Weibman, D., Halperin, J. M., & Li, X. (2019) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2019.00042 · Cited by 394
Associations of sleep disturbance with ADHD: implications for treatment
Hvolby, A. (2015) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-014-0151-0 · Cited by 339
Evidence-based pharmacological treatment options for ADHD in children and adolescents
Mechler, K., Banaschewski, T., Hohmann, S., & Häge, A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107940 · Cited by 293
Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review
Sikirica, V., Lü, M., Greven, P., Zhong, Y., Qin, P., Xie, J., & Gajria, K. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s65721 · Cited by 229
Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy
Setnik, B., McDonnell, M., Mills, C., Scart‐Grès, C., Robert, P., Dayno, J. M., & Schwartz, J.-C. (2019) · SLEEP · doi:10.1093/sleep/zsz252 · Cited by 189

See all 147

Authors: Hodgkins, P., Shaw, M., Coghill, D., & Hechtman, L.
Affiliations: Norgine (United Kingdom) (GB)
University of Dundee (GB)
Montreal Children's Hospital (CA)
Corresponding author: Hodgkins, Paul
ORCID: Coghill, David
Hechtman, Lily
Venue: European Child & Adolescent Psychiatry
Publisher: Springer Science and Business Media LLC
Published: 2012-07-05
Volume: 21
Issue: 9
Pages: 477-492
ISSN: 1018-8827 (ISSN-L)
1435-165X
DOI: 10.1007/s00787-012-0286-5
PMC: PMC3432777
OpenAlex: W2117621614
Cited by: 147
References: 101
Citations by year: 2026: 9 · 2025: 6 · 2024: 15 · 2023: 14 · 2022: 16 · 2021: 9 · 2020: 14 · 2019: 11 · 2018: 5 · 2017: 10 · 2016: 9 · 2015: 5 · 2014: 18 · 2013: 6
FWCI: 1.25
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
Locations: European Child & Adolescent Psychiatry (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
Discovery Research Portal (University of Dundee) (publishedVersion)
Minerva Access (University of Melbourne) (submittedVersion, cc-by)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
Keywords: attention deficit hyperactivity disorder, amphetamine, methylphenidate, stimulant medication, children and adolescents, treatment efficacy, drug safety, medication adherence, non-pharmacological treatment, personalized treatment
MeSH terms: Amphetamine, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Humans, Methylphenidate, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks